Bernstein maintains Biocon at Outperform

  • Investing.com
Bernstein maintains Biocon at Outperform

A Bernstein analyst maintained Biocon (NS: BION) at Outperform and a price target of $299.00.

Prior to this rating, Biocon had 12 buy ratings, 4 hold ratings, and 5 sell ratings.

For consensus analyst estimates and price targets on Biocon, click here. For more news on Biocon, click here.

Biocon's stock price closed at $198.70. They are up 0% in the last month and down -43.05% in the last 12 months.

According to Investing Pro, Biocon's fair value is $308.80, an upside of 55.41%. Biocon's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Biocon's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles